©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114743
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114743
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114743
Table 3 Multivariable logistic regression analysis of independent variables for prediction of time to adjuvant chemotherapy, completion of adjuvant chemotherapy, 1-year, 3-years and overall survival
| Variable | Time to AC | Completion of AC | 1-year survival | 3-years survival | Overall survival | |||||
| Standardized coefficient | P value | Standardized coefficient | P value | Standardized coefficient | P value | Standardized coefficient | P value | Standardized coefficient | P value | |
| PMI | -0.0109 | 0.2405 | -0.0003 | 0.1985 | 0.0001 | 0.3790 | 0.0001 | 0.9774 | 0.3140 | 0.3065 |
| HUAC | 0.5074 | 0.0005 | 0.0124 | 0.0486 | 0.0005 | 0.8616 | 0.0020 | 0.5941 | 0.4704 | 0.9206 |
| Sarcopenia | 6.3857 | 0.1676 | 0.2114 | 0.1188 | -0.0059 | 0.9531 | 0.0551 | 0.6641 | -33.5165 | 0.8262 |
| Age | 0.1439 | 0.4434 | -0.0036 | 0.5082 | -0.0074 | 0.0689 | 0.0010 | 0.8328 | -1.6205 | 0.7927 |
| Octogenarian | 2.9289 | 0.7158 | 0.2488 | 0.2923 | 0.2749 | 0.1151 | 0.5160 | 0.0201 | 538.2032 | 0.0433 |
| ASA | 1.7999 | 0.4676 | 0.0005 | 0.9941 | 0.0031 | 0.9535 | 0.0326 | 0.6292 | 45.9027 | 0.5729 |
| CR-POPF | 7.2686 | 0.1739 | 0.1050 | 0.5017 | 0.0878 | 0.4456 | 0.0525 | 0.7182 | 228.5744 | 0.1931 |
| C-D > III | 5.9580 | 0.3445 | 0.0764 | 0.6788 | -0.0841 | 0.5361 | -0.0448 | 0.7943 | -106.1970 | 0.6078 |
| LOS | 0.6556 | 0.0076 | -0.0033 | 0.6392 | -0.0010 | 0.8462 | -0.0101 | 0.1290 | -7.6509 | 0.3385 |
| Cardiac disease | 2.8105 | 0.5780 | -0.1286 | 0.3855 | -0.0572 | 0.5997 | -0.2473 | 0.0747 | -291.7777 | 0.0804 |
| COPD | -9.9204 | 0.1640 | 0.4382 | 0.0368 | 0.1614 | 0.2935 | 0.1030 | 0.5954 | 111.0465 | 0.6344 |
- Citation: Hajibandeh S, Hajibandeh S, Mckittrick H, Imrani U, Varghese A, Balasubramaniam R, Durkin D, Athwal TS. Psoas muscle variables and adjuvant chemotherapy-related and survival outcomes following pancreaticoduodenectomy for periampullary malignancy. World J Gastrointest Surg 2026; 18(2): 114743
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/114743.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.114743